Chris Olave
NO

Chris Olave

WRBye Wk 8● med injury riskMarket ADP 25 · WR12
Updated Sep 3, 2026
Per-game floor / ceiling · half-PPRProj. games: 15.6 / 17
Floor10.9
Proj.12.7
Ceiling15.2
AI outlook

Locked-in WR1 for Tyler Shough after 4-yr/$132M extension (Aug 2026). 2025: 100/1163/9 on 156 targets, 29% target share. Fully cleared from lung blood clot; concussion history flagged as tail-risk, not a games-played haircut. Rookie WR Jordyn Tyson adds mild target-dilution risk.

Recent news
Olave has the wind knocked out of him at practice, no structural issueLouisiana Sports/ClutchPoints

Olave landed hard on his back going up for a deep ball Aug 25; HC Kellen Moore said he just had the wind knocked out of him, no structural issue found by medical staff. Resolved as a non-event -- no outlook change.

Strengths & concerns
Pros / cons +

Pros

  • Signed 4-yr/$132M extension Aug 2026 - highest-paid Saints WR ever, cements alpha role (Fox News, 2026-08)
  • 2025: 100 rec/1163 yds/9 TD on 156 targets, 29% target share (9th in NFL)
  • 17-game pace of 102/1403/13 in the 8 games with Shough at QB - carries real 2026 continuity
  • Fully cleared, no limitations, from blood clot issue; full camp participation late July 2026 (NFL.com, Yardbarker)

Cons

  • 4-5 documented concussions since 2022, incl. one that ended part of 2024 season - cumulative repeat-injury risk (NFL.com)
  • 2025 blood clot in lung is a new, separate medical flag to monitor despite current clearance
  • Rookie 1st-rounder Jordyn Tyson now a real WR2 behind him - some target-share dilution risk off 2025's 29% share
  • O-line still unsettled: RT Taliese Fuaga has recurring injury concerns; 2026 pace/PROE unconfirmed
Why our rank differs from ADP
agree

Not available yet.

Full breakdown +

Not available yet.

Our model
Market ADP?25
Blended rank?23
Consensus rank?23
Tier?Tier 5
VBD score?95.9
Risk profile

Coming soon — we're rebuilding this rating from scratch to make it more accurate.

Projected PPG
Standard9.8
Half-PPR12.7
Full PPR15.7
Confidence tier
Med